apexigen.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Crawl-delay: | ||
Meta Tags
| Title | Apexigen | Immuno-oncology | |
| Description | About Apexigen is a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for the treatment of cancer with an emphasis on new immuno-oncology |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 69.63.140.80 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
apexigen.com Valuation
|
US$8,324,888
Last updated: 2023-05-08 00:11:27
apexigen.com has Semrush global rank of 1,271,405. apexigen.com has an estimated worth of US$ 8,324,888, based on its estimated Ads revenue. apexigen.com receives approximately 960,564 unique visitors each day. Its web server is located in United States, with IP address 69.63.140.80. According to SiteAdvisor, apexigen.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$8,324,888 |
| Daily Ads Revenue | US$7,685 |
| Monthly Ads Revenue | US$230,536 |
| Yearly Ads Revenue | US$2,766,425 |
| Daily Unique Visitors | 64,038 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| apexigen.com. | A | 3599 | IP: 69.63.140.80 |
| apexigen.com. | NS | 3600 | NS Record: ns30.domaincontrol.com. |
| apexigen.com. | NS | 3600 | NS Record: ns29.domaincontrol.com. |
| apexigen.com. | MX | 3600 | MX Record: 20 d148905b.ess.barracudanetworks.com. |
| apexigen.com. | MX | 3600 | MX Record: 10 d148905a.ess.barracudanetworks.com. |
| apexigen.com. | TXT | 3600 | TXT Record: MS=ms23367381 |
| apexigen.com. | TXT | 3600 | TXT Record: v=spf1 mx a ip4:68.65.65.148 -all |
HtmlToTextCheckTime:2023-05-08 00:11:27
| About Apexigen is a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics for the treatment of cancer with an emphasis on new immuno-oncology products designed to harness the patient’s immune system to combat and eradicate cancer. Immuno-oncology Recent advances in cancer immunology have increased our understanding of the mechanisms that cancer cells use to either avoid detection by or to de-activate the immune system. Novel immuno-oncology drugs are designed specifically to block immune suppression induced by tumors, or to actively initiate and augment an immune response against tumors. Harnessing the body’s immune system has the potential to eliminate tumors and prevent their recurrence. Apexigen’s Immuno-oncology Strategy Apexigen is focused on discovering and developing innovative drugs that enhance tumor-specific immunity. The use of its APXiMAB™ platform enables Apexigen to discover antibodies with unique attributes against |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Fri, 29 Oct 2021 00:37:18 GMT Server: Apache Location: https://www.apexigen.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Fri, 29 Oct 2021 00:37:19 GMT Server: Apache Vary: User-Agent,Accept-Encoding Last-Modified: Thu, 28 Oct 2021 16:54:56 GMT Cache-Control: max-age=30, s-maxage=30 Expires: Fri, 29 Oct 2021 00:37:49 GMT X-Frame-Options: SAMEORIGIN X-Content-Type-Options: nosniff X-XSS-Protection: 1; mode=block Strict-Transport-Security-Test: max-age=60 Strict-Transport-Security: max-age=15768000 Content-Security-Policy: default-src 'self' data:; report-uri /csp.cfm; style-src 'self' 'unsafe-inline' fonts.googleapis.com *.typekit.net; font-src 'self' data: https:; frame-ancestors 'self'; frame-src 'self' player.vimeo.com *.youtube.com www.google.com; script-src 'self' 'unsafe-eval' 'unsafe-inline' ajax.googleapis.com www.google-analytics.com; img-src 'self' data: www.google-analytics.com; connect-src 'self' www.google-analytics.com Content-Type: text/html;charset=UTF-8 |
apexigen.com Whois Information
Domain Name: APEXIGEN.COM Registry Domain ID: 1610563390_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-08-11T12:16:06Z Creation Date: 2010-08-11T00:00:27Z Registry Expiry Date: 2025-08-11T00:00:27Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS29.DOMAINCONTROL.COM Name Server: NS30.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T15:28:07Z <<< |